Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients

[1]  H. Abboudi,et al.  Metallic Ureteric Stents in Malignant Ureteric Obstruction: A Systematic Review. , 2018, Urology.

[2]  I. Chiang,et al.  The effectiveness and durability of ureteral tumor stent, the national taiwan university hospital experience , 2017, Urological Science.

[3]  A. Dirim,et al.  Tandem ureteral stents in the management of double-J stent dysfunction in gynecological malignancies. , 2017, Diagnostic and interventional imaging.

[4]  K. Anson,et al.  The Role of Tandem Double-J Ureteral Stents in the Management of Malignant Ureteral Obstruction. , 2016, Journal of endourology.

[5]  M. Srougi,et al.  A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients , 2016, BJU international.

[6]  Chao-yuan Huang,et al.  Malignant Ureteral Obstruction: Functional Duration of Metallic versus Polymeric Ureteral Stents , 2015, PloS one.

[7]  Arthur D. Smith,et al.  Stenting for malignant ureteral obstruction: Tandem, metal or metal‐mesh stents , 2015, International journal of urology : official journal of the Japanese Urological Association.

[8]  Y. Bao,et al.  The use of internal stents in chronic ureteral obstruction. , 2015, The Journal of urology.

[9]  J. Lee,et al.  Comparison of efficacy and safety between a segmental thermo-expandable metal alloy spiral stent (Memokath 051) and a self-expandable covered metallic stent (UVENTA) in the management of ureteral obstructions. , 2014, Journal of laparoendoscopic & advanced surgical techniques. Part A.

[10]  D. Moreira,et al.  Tandem ureteral stents for the decompression of malignant and benign obstructive uropathy. , 2013, Journal of endourology.

[11]  B. Park,et al.  Efficacy and safety of a novel, double-layered, coated, self-expandable metallic mesh stent (Uventa™) in malignant ureteral obstructions. , 2013, Journal of endourology.

[12]  Chin-Shang Li,et al.  Quality-of-Life Assessment After Palliative Interventions to Manage Malignant Ureteral Obstruction , 2013, CardioVascular and Interventional Radiology.

[13]  K. Ahrar,et al.  Nephrostomy tube related pyelonephritis in patients with cancer: epidemiology, infection rate and risk factors. , 2013, The Journal of urology.

[14]  Sang Woo Park,et al.  Multicenter Experience of the Newly Designed Covered Metallic Ureteral Stent for Malignant Ureteral Occlusion: Comparison With Double J Stent Insertion , 2013, CardioVascular and Interventional Radiology.

[15]  O. Nativ,et al.  A new self-expanding, large-caliber ureteral stent: results of a multicenter experience. , 2012, Journal of endourology.

[16]  Jae Han Kim,et al.  Palliative Care of Malignant Ureteral Obstruction with Polytetrafluoroethylene Membrane-Covered Self-Expandable Metallic Stents: Initial Experience , 2012, Korean journal of urology.

[17]  Yongsheng Song,et al.  Percutaneous Nephrostomy Versus Indwelling Ureteral Stent in the Management of Gynecological Malignancies , 2011, International Journal of Gynecologic Cancer.

[18]  Hung-Chieh Chen,et al.  Parallel second stent placement for refractory ureteral stent malfunction in malignant ureteral obstruction. , 2011, Journal of vascular and interventional radiology : JVIR.

[19]  R. Autorino,et al.  Predictors of morbidity in patients with indwelling ureteric stents: results of a prospective study using the validated Ureteric Stent Symptoms Questionnaire , 2011, BJU international.

[20]  K. Izumi,et al.  Current outcome of patients with ureteral stents for the management of malignant ureteral obstruction. , 2011, The Journal of urology.

[21]  R. Kulkarni,et al.  The thermo‐expandable metallic ureteric stent: an 11‐year follow‐up , 2009, BJU international.

[22]  K. Kihara,et al.  Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases. , 2008, The Journal of urology.

[23]  E. Wallen,et al.  Management of ureteral obstruction due to advanced malignancy: optimizing therapeutic and palliative outcomes. , 2008, The Journal of urology.

[24]  E. Hyams,et al.  Malignant extrinsic ureteral obstruction: a survey of urologists and medical oncologists regarding treatment patterns and preferences. , 2008, Urology.

[25]  W. Roberts,et al.  UROLITHIASIS, ENDOUROLOGY AND LAPAROSCOPY Retrograde Ureteral Stents for Extrinsic Ureteral Obstruction: Nine Years' Experience at University of Michigan , 2008 .

[26]  L. Wong,et al.  Malignant ureteral obstruction: outcomes after intervention. Have things changed? , 2007, The Journal of urology.

[27]  K. Hausegger,et al.  Percutaneous nephrostomy and antegrade ureteral stenting: technique—indications—complications , 2006, European Radiology.

[28]  F. Erdemir,et al.  Using Two Ipsilateral Double J Ureteral Stents for Extrinsic Ureteral Obstruction due to Colon Carcinoma , 2005, Urologia Internationalis.

[29]  K. Loughlin,et al.  The management of malignant ureteral obstruction treated with ureteral stents. , 2005, The Journal of urology.

[30]  N. Cowan,et al.  Retrograde or antegrade double-pigtail stent placement for malignant ureteric obstruction? , 2005, Clinical radiology.

[31]  P. Klarskov,et al.  Experience with Memokath 051 ureteral stent , 2005, Scandinavian journal of urology and nephrology.

[32]  D. Wood,et al.  Stent-change therapy in advanced malignancies with ureteral obstruction. , 2005, Journal of endourology.

[33]  Douglas Landsittel,et al.  15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents. , 2004, The Journal of urology.

[34]  A. Magnusson,et al.  Complications associated with percutaneous nephrostomies. a retrospective study , 2004, Acta radiologica.

[35]  N. Burgess,et al.  The management of ureteric obstruction secondary to malignant pelvic disease. , 2002, Clinical radiology.

[36]  P. Kavanagh,et al.  Complications of ureteral stent placement. , 2002, Radiographics : a review publication of the Radiological Society of North America, Inc.

[37]  A. Shabsigh,et al.  Simultaneous multiple double pigtail stents for malignant ureteral obstruction. , 2002, Urology.

[38]  B. Lee,et al.  Management of malignant extrinsic compression of the ureter by simultaneous placement of two ipsilateral ureteral stents. , 2001, Journal of endourology.

[39]  D. Lifshitz,et al.  Predicting the success of retrograde stenting for managing ureteral obstruction. , 2001, The Journal of urology.

[40]  K. Malagari,et al.  Complications of Percutaneous Nephrostomy, Percutaneous Insertion of Ureteral Endoprosthesis, and Replacement Procedures , 2001, CardioVascular and Interventional Radiology.

[41]  M. Shalev,et al.  The indwelling ureteric stent: a ‘friendly’ procedure with unfriendly high morbidity , 2000, BJU international.

[42]  G. Bellman,et al.  Management of ureteral obstruction secondary to pelvic malignancies. , 1999, Journal of endourology.

[43]  R. Hrebinko,et al.  The use of 2 ipsilateral ureteral stents for relief of ureteral obstruction from extrinsic compression. , 1998, The Journal of urology.

[44]  S. Sharma,et al.  A review of antegrade stenting in the management of the obstructed kidney. , 1996, British journal of urology.

[45]  D. Lu,et al.  Percutaneous internal ureteral stent placement: review of technical issues and solutions in 50 consecutive cases. , 1994, Clinical radiology.

[46]  J. Rösch,et al.  Antegrade internal ureteral stenting: a technical refinement. , 1985, Radiology.

[47]  J. Grayhack,et al.  Palliative urinary diversion for malignant ureteral obstruction. , 1978, The Journal of urology.